Curcumin Ameliorates Neuroinflammation, Neurodegeneration, and Memory Deficits in p25 Transgenic Mouse Model that Bears Hallmarks of Alzheimer’s Disease
Open accessAbstract
Several studies have indicated that neuroinflammation is indeed associated with neurodegenerative disease pathology. However, failures of recent clinical trials of anti-inflammatory agents in neurodegenerative disorders have emphasized the need to better understand the complexity of the neuroinflammatory process in order to unravel its link with neurodegeneration. Deregulation of Cyclin-dependent kinase 5 (Cdk5) activity by production of its hyperactivator p25 is involved in the formation of tau and amyloid pathology reminiscent of Alzheimer's disease (AD). Recent studies show an association between p25/Cdk5 hyperactivation and robust neuroinflammation. In addition, we recently reported the novel link between the p25/Cdk5 hyperactivation-induced inflammatory responses and neurodegenerative changes using a transgenic mouse that overexpresses p25 (p25Tg). In this study, we aimed to understand the effects of early intervention with a potent natural anti-inflammatory agent, curcumin, on p25-mediated neuroinflammation and the progression of neurodegeneration in p25Tg mice. The results from this study showed that curcumin effectively counteracted the p25-mediated glial activation and pro-inflammatory chemokines/cytokines production in p25Tg mice. Moreover, this curcumin-mediated suppression of neuroinflammation reduced the progression of p25-induced tau/amyloid pathology and in turn ameliorated the p25-induced cognitive impairments. It is widely acknowledged that to treat AD, one must target the early-stage of pathological changes to protect neurons from irreversible damage. In line with this, our results demonstrated that early intervention of inflammation could reduce the progression of AD-like pathological outcomes. Moreover, our data provide a rationale for the potential use of curcuminoids in the treatment of inflammation associated neurodegenerative diseases.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Curcumin inhibits p25-mediated glial activation and production of pro-inflammatory chemokines and cytokines in p25Tg mice.
“Moreover, they demonstrated that curcumin substantially inhibited p25-mediated glial activation and the production of pro-inflammatory chemokines and cytokines in p25Tg mice.”
From Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights (2023) · cites this paper as [87]
Curcumin-mediated inhibition of neuroinflammation slows tau/amyloid pathology and improves cognitive deficits in p25 mice.
“Additionally, this curcumin-mediated inhibition of neuroinflammation slowed the advancement of the tau/amyloid pathology caused by p25, which in turn improved the cognitive deficits caused by p25.”
From Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights (2023) · cites this paper as [87]
p25/Cdk5 hyperactivation is associated with robust neuroinflammation.
“Sundaram et al. have revealed an association between p25/Cdk5 hyperactivation and robust neuroinflammation.”
From Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights (2023) · cites this paper as [87]
Curcumin has anti-inflammatory action on p25-mediated neuroinflammation and slows neurodegeneration in p25Tg mice.
“They confirmed the anti-inflammatory action of curcumin on p25-mediated neuroinflammation and the progression of neurodegeneration in p25Tg mice.”
From Unlocking the Therapeutic Potential of Medicinal Plants for Alzheimer’s Disease: Preclinical to Clinical Trial Insights (2023) · cites this paper as [87]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 62 · Cited by 105
- Authors
- Sundaram, J. R., Poore, C. P., Sulaimee, N. H. B., Pareek, T., Cheong, W. F., Wenk, M. R., Pant, H. C., Frautschy, S. A., Low, C.-M., & Kesavapany, S.
- Affiliations
- National University of Singapore (SG)
- Case Western Reserve University (US)
- National Institutes of Health (US)
- University of California, Los Angeles (US)
- Corresponding author
- Kesavapany, Sashi
- Venue
- Journal of Alzheimer s Disease
- Publisher
- SAGE Publications
- Published
- 2017-11-07
- Volume
- 60
- Issue
- 4
- Pages
- 1429-1442
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- PMC
- PMC8092919
- OpenAlex
- W2761591067
- Cited by
- 105
- References
- 62
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 14 · 2023: 12 · 2022: 14 · 2021: 14 · 2020: 16 · 2019: 9 · 2018: 6
- FWCI
- 6.27
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Alzheimer s Disease (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- National University of Singapore (submittedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 RX000669, I01 BX001257, I01 BX003485, I01 BX000542)
- National Institute on Aging (R21AG050269)
- National Center for Complementary and Integrative Health (R01AT006816)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Curcumin's Biomedical Applications
- Keywords
- curcumin, neuroinflammation
- MeSH terms
- Alzheimer Disease, Animals, Anti-Inflammatory Agents, Astrocytes, Brain, Curcumin, Humans, Inflammation, Memory Disorders, Mice, Inbred CBA, Mice, Inbred C57BL, Mice, Transgenic, Nerve Degeneration, Neuroimmunomodulation, Neuroprotective Agents, Nootropic Agents, Calcium-Calmodulin-Dependent Protein Kinase Type 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review